Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Sorrento Therpt
(NQ:
SRNE
)
9.500
USD
+1.510 (+18.90%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Sorrento Therpt
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Joint Ventures for Untapped Research Area - Report on Sorrento Therapeutics
July 22, 2015
From
PR Newswire
Sorrento Announces Departure of Mr. George Uy to become CEO of Start-up Company
July 17, 2015
From
PR Newswire
Updates on Biotechnology Industry Stocks -- ZIOPHARM Oncology, Novavax, Galena Biopharma, Sorrento Therapeutics, and Aegerion Pharma
July 17, 2015
From
PR Newswire
Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
July 09, 2015
From
PR Newswire
Globavir Exclusively Licenses Oncology Program to Sorrento Therapeutics
July 08, 2015
From
PR Newswire
Sorrento and NantBioScience Form Joint Venture to Develop Moonshot Program Targeted Small Molecule Therapies against Cancer
July 08, 2015
-- Jointly commit $100M to develop c-Myc,HIF-1 alpha, ?and TRAIL therapeutic programs?
From
PR Newswire
Sorrento Added to Russell 2000 Small Cap, Russell 3000 and Global Indexes
June 29, 2015
From
PR Newswire
ARK Animal Health, a Subsidiary of Sorrento Therapeutics, Announces Receipt of MUMS Drug Designation in Dogs
June 24, 2015
From
PR Newswire
Sorrento to Present at the 2015 Jefferies Healthcare Conference and at Other Conferences
May 26, 2015
From
PR Newswire
Advaxis and Sorrento Form Collaboration to Evaluate Combinations of Advaxis's Lm-LLO Immunotherapy Technology and Sorrento's Immunomodulatory Antibodies
May 19, 2015
From
GlobeNewswire News Releases
Sorrento Establishes TNK Therapeutics Subsidiary with Focus on Cellular Immunotherapies
May 18, 2015
- Pipeline to include 'off-the-shelf' CAR.TNKs™ as well as complementary cellular and immunotherapies
From
PR Newswire
NantWorks Acquires Cynviloq™ For Up To $1.3+ Billion
May 15, 2015
--$90 million+ up-front payment and $1.2 billion+ milestone payments
From
PR Newswire
An Opportunity in the Shifting Perceptions of the FDA
May 12, 2015
Tags
Publishing & Media
From
ACCESSWIRE
Pulse of the Healthcare Sector: Complementary Research on Sorrento, Aoxing, Neuralstem, ICU Medical and Avalanche Biotechnologies
May 11, 2015
From
PR Newswire
Sorrento Announces Positive TRIBECA™ Registrational Study Results
May 04, 2015
From
PR Newswire
Sorrento Acquires South American Rights To Cynviloq™
May 01, 2015
From
PR Newswire
Sorrento Announces the Appointments of David H. Deming to the Board of Directors and Mark W. Durand as Chief Financial Officer
April 30, 2015
From
PR Newswire
Sorrento Therapeutics Announces Three Preclinical Poster Presentations on Cynviloq™, its Novel Antibody Drug Conjugate Linker Technology and c-Met/EGFR Bispecific ADC at the 106th Annual Meeting of th
April 18, 2015
From
PR Newswire
Sorrento to Present at Jefferies 2015 Immuno-Oncology Summit
April 13, 2015
SRNE Included Among "25 Top Immunotherapy Companies" in Newly Launched Loncar Cancer Immunotherapy Index (LCINDX)
From
PR Newswire
Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer
March 30, 2015
From
PR Newswire
NantWorks And Sorrento Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies
March 16, 2015
NantCell To Acquire Exclusive Rights to Antibodies Including CAR-TNK™ Products and the Checkpoint Inhibitors PD-1 and PD-L1
From
PR Newswire
How It All Plays Out: Latest Research on PAREXEL, Senomyx, Sorrento Therapeutics, Tenax Therapeutics, and Charles River
February 26, 2015
From
PR Newswire
Sorrento to Present at Cowen and Company's 35th Annual Health Care Conference
February 23, 2015
From
PR Newswire
Sorrento to Present at the 17th Annual BIO CEO & Investor Conference
February 05, 2015
From
PR Newswire
Sorrento Announces Retention of Glen Sato to Provide Strategic Support
February 02, 2015
From
PR Newswire
Sorrento Announces Completion of Enrollment in the Cynviloq™ Registrational TRIBECA™ Study
January 28, 2015
From
PR Newswire
Sorrento Provides Status Update on the Cynviloq™ Registrational TRIBECA™ Study
January 12, 2015
From
PR Newswire
Conkwest, Sorrento And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong
January 06, 2015
From
PR Newswire
Sorrento To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco
January 05, 2015
From
PR Newswire
Conkwest Appoints Robert Rosen and Henry Ji to its Board of Directors
December 29, 2014
From
Business Wire News Releases
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.